SORT BY

FILTER BY

also on other fortune lists

company facts

g500 stats

Global 500

Courtesy of AbbVie

469

AbbVie

ABBV

U.S.

The pharmaceutical company makes drugs to treat HIV, psoriasis, rheumatiod arthritis, low testosterone, thyroid problems, and Parkinson’s.

CEO

Richard A. Gonzalez

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

North Chicago, IL

Employees

28,000

Years on Global 500 List

1

Key Financials (last fiscal year)
($ Millions)% change
Revenues ($M)$22,85914.5%
Profits ($M)$5,144190.0%
Assets ($M)$53,050
Total Stockholder Equity ($M)$3,945
Profit Ratios
Profit as % of Revenues22.5%
Profits as % of Assets9.7%
Profits as % of Stockholder Equity130.4%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about AbbVie

How the Best Workplaces in Health Care and Biopharma Are Winning the Talent War

Fortune research partner Great Place to Work has released its 2019 list of the best workplaces in health care and biopharma.

Read More →
Senator Calls Tying Drugmaker CEO Pay to High Drug Price 'Problematic'

A year's course of the blockbuster drug is $60,000, more than triple its initial 2012 price.

Read More →
Fortune's Blue Ribbon Companies 2018

These 56 companies are on at least four of Fortune's 2018 rankings.

Read More →
Drugmakers Celebrate the New Year by Raising Prices on Hundreds of Drugs an Average of 6.3%

The average price increase is nearly three times the current U.S. inflation rate.

Read More →
AbbVie Gets OK for Potential Blockbuster Endometriosis Treatment

AbbVie Inc. won U.S. approval for an oral medicine that treats pain caused by the gynecological disorder endometriosis.

Read More →

Videos about AbbVie